NMTC
NASD NeuroOne Medical Technologies Corporation$1.16 ↑ +0.17 (+17.75%) Trading Up from the previous close of $0.99, $0.04 below the day’s high of $1.20
- YTD change
- -74.49%
- vs 20-day SMA
- -17.07%
- vs 200-day SMA
- -67.76%
Price ranges
Price & Performance
+0.19 (+23.91%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.6% away from all-time highs of $47.82
- NMTC is down 74% since the beginning of the year
- NMTC is down 79% over the past 12 months
- NMTC is down 31% over the past 1 month
- 1% of all NMTC investors are betting against NMTC
NMTC reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +9.5%.
- Previous minute
- +$0.02
- Last hour
- -$0.01
- Last 5 days
- -12.78%
- vs 8-day SMA
- -5.16%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.